From: Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Age, years | 61.5 (40–77) |
Female sex | 6 (9.5%) |
Smoking | 45 (71.4%) |
ECOG-PS | |
0 | 27 (42.9%) |
1 | 27 (42.9%) |
2 | 9 (14.2%) |
Subtype | |
Urothelial | 29 (46%) |
Papillary urothelial | 23 (36.5%) |
SCC | 3 (4.8) |
Others | 8 (12.7) |
Stage | |
2 | 7 (11.1) |
3a | 25 (39.7) |
3b | 31 (49.2) |
After neoadjuvant | |
Pathological responsive | 19 (55.9%) |
Pathological unresponsive | 15 (44.1%) |
Type of surgery | |
Radical cystectomy | 59 (93.6%) |
Partial cystectomy | 3 (4.8%) |
Radical cystectomy + nephrectomy + ureterectomy | 1 (1.6%) |